Dominik Adamowicz

Dominik Adamowicz

Auto-generated profile, based on publicly available information

Dominik Adamowicz

University Clinical Centre of the Medical University of Warsaw, Banacha 1a, 02-097 Warszawa

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2023 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
PRPatryk Rudzinski
Patryk Rudzinski
ILInga Lopuszynska
Inga Lopuszynska
DPDorota Pazik
Dorota Pazik
DADominik Adamowicz
Dominik Adamowicz
AJAnna Jargielo
Anna Jargielo
AWAlicja Wosinska
Alicja Wosinska

6 September 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JZJulita Kinga Zembala
Julita Kinga Zembala
AFAlicja Forma
Alicja Forma
RZRoksana Zembala
Roksana Zembala
JJJacek Januszewski
Jacek Januszewski
PZPatryk Zembala
Patryk Zembala
Jacek BajJacek Baj
Jacek Baj
Glaucoma is a leading cause of irreversible blindness and is characterized by increased intraocular pressure (IOP) and progressive optic nerve damage. The current therapeutic approaches for glaucoma management, such as eye drops and oral medications, face challenges including poor bioavailability, low patient compliance, and limited efficacy. In recent years, nanotechnology has emerged as a promising approach to overcome these limitations and revolutionize glaucoma treatment. In this narrative review, we present an overview of the novel nanotechnologies employed in the treatment of primary open-angle glaucoma. Various nanosystems, including liposomes, niosomes, nanoparticles, and other nanostructured carriers, have been developed to enhance the delivery and bioavailability of antiglaucoma drugs. They offer advantages such as a high drug loading capacity, sustained release, improved corneal permeability, and targeted drug delivery to the ocular tissues. The application of nanotechnologies in glaucoma treatment represents a transformative approach that addresses the limitations of conventional therapies. However, further research is needed to optimize the formulations, evaluate long-term safety, and implement these nanotechnologies into clinical practice. With continued advancements in nanotechnology, the future holds great potential for improving the management and outcomes of glaucoma, ultimately preserving vision and improving the lives of millions affected by this debilitating disease.

19 August 2023 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
IŁInga Łopuszyńska
Inga Łopuszyńska
DADominik Adamowicz
Dominik Adamowicz
PRPatryk Rudzinski
Patryk Rudzinski
AWAlicja Wosińska
Alicja Wosińska
AMAstrik Meliksetian
Astrik Meliksetian
KKKarolina Kosieradzka
Karolina Kosieradzka
Introduction and aim. The World Health Organization (WHO) reports that around 11 million people experience burn injuries each year.1,2 Burn injuries occur when tissue damage is caused by various factors such as UV radiation, heat, chemicals, or electric current.3,4 While burns primarily affect the skin, they can also extend to deeper tissues like bones or muscles. When the skin is burned, its vital functions, including protection against the external environment, pathogens, and evaporation, are compromised.1 The appropriate treatment method must be chosen based on the burn stage, the patient's condition, and the cause. The aim of this paper is to provide a comprehensive review based on literature, concerning superficial burns and sunburns treatment, with a focus on nature-derived topical treatment methods. Material and methods. PubMed database was searched for the following terms: “burns”, “burn treatment”, “aloe vera”, “sunburn”, “centella asiatica”, “climate change”, “wound healing” for the articles published between 2005-2023 and written in the English language. Conclusion. Herbal-derived compounds, with their diverse mechanisms of action, antibacterial activity, and safety profiles present a competitive alternative to conventional treatment of burns and sunburns, however, there are still not enough clinical trials to assess the effectiveness and safety profiles of nature-derived compounds.

19 August 2023 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
PZPatryk Zembala
Patryk Zembala
JZJulita Kinga Zembala
Julita Kinga Zembala
RZRoksana Zembala
Roksana Zembala
DADominik Adamowicz
Dominik Adamowicz
EGEwa Gacoń
Ewa Gacoń
IŁInga Łopuszyńska
Inga Łopuszyńska
Introduction and objective Gel nail allergies have become a growing concern in recent years, as individuals experience adverse immune reactions to the chemicals present in gel nail products. The popularity of gel nails, known for their long-lasting and durable finish compared to traditional nail polishes, has increased in the beauty industry. However, specific constituents, particularly acrylate compounds used in gel nail formulations, can trigger allergic responses in susceptible individuals. Abbreviated description of the state of knowledge Findings from the reviewed articles indicate that allergic reactions to acrylates in gel nail products can manifest in various ways, including contact dermatitis, dermatoses, and general allergic responses. Nail technicians, due to their frequent exposure to gel nail products and other potential allergens, are particularly vulnerable to occupational hazards associated with acrylate sensitization. These insights highlight the need for preventive measures to protect the health and well-being of nail technicians and promote a safer working environment. Summary This literature review addresses the emerging issue of gel nail allergies and provides valuable information regarding the prevalence and characteristics of allergic reactions to acrylates. The article underscores the significance of increasing awareness, implementing preventive measures, and effectively managing gel nail allergies. By doing so, the beauty industry can ensure a safer approach to gel nail applications, benefitting both nail technicians and consumers alike.

14 April 2023 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
AWAlicja Wosińska
Alicja Wosińska
DPDorota Pazik
Dorota Pazik
IŁInga Łopuszyńska
Inga Łopuszyńska
KKKatarzyna Kosecka
Katarzyna Kosecka
PRPatryk Rudzinski
Patryk Rudzinski
JSJustyna Stańczyk
Justyna Stańczyk
Introduction: The complex symbiotic connection between the host and the gut microbiome, which has many important functions in the organism, provides an opportunity for dysbiosis to potentially serve as a catalyst for various health disorders. Akkermancia muciniphila, a bacterium that degadates mucin, is a noteworthy element of the human gut microbiome and has captured the attention of researchers due to its correlation with numerous diseases. Aim of the study: The purpose of this research was to review literature and determine the impact of Akkermansia muciniphila in selected diseases. A systematic review was conducted using PubMed database. State of knowledge: Studies have shown that reduced numbers of Akkermansia muciniphila have been associated with many diseases, including obesity, type 2 diabetes, atherosclerosis, fatty liver, some neurological conditions, inflammation, and response to cancer immunotherapies. Furthermore, the administration of this bacterium has been shown to have a positive impact on reducing obesity-related parameters, improving insulin sensitivity and glucose homeostasis, mitigating inflammation, and enhancing the prognosis of immune checkpoint inhibitor treatment. Conclusions: The condition and composition of the intestinal microbiome play a significant role in the development and progression of numerous diseases. Akkermansia muciniphila, as demonstrated in various studies, is an example of a bacterium associated with beneficial effects in multiple diseases. It is regarded as a promising candidate for probiotic use.

25 April 2023 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
KKKarolina Kosieradzka
Karolina Kosieradzka
KKKatarzyna Kosecka
Katarzyna Kosecka
PRPatryk Rudzinski
Patryk Rudzinski
ACAleksandra Cieślik
Aleksandra Cieślik
DADominik Adamowicz
Dominik Adamowicz
AJAnna Jargieło
Anna Jargieło
Introduction: Metabolic syndrome, prediabetes and type 2 diabetes mellitus represent a growing and interconnected health challenge, gaining significant attention due to their high prevalence and impact they have on individuals' well-being. Intermittent Fasting (IF), involving cycling between periods of fasting and eating, has emerged as a promising dietary approach garnering substantial attention for its potential therapeutic effects on metabolic health. Purpose: This review aims to explore the impact of intermittent fasting on metabolic disease by examining recent studies. Methods: A review of the recent literature was conducted to explore potential positive effects of IF on relevant metabolic parameters. Results: The findings from the reviewed studies demonstrated favorable effects of IF associated with improvements in glycemic control as improved insulin sensitivity and decreased HbA1c levels. Additionally, it led to significant reductions in body weight and waist circumference. Beneficial effects on lipid profiles, such as reduced triglyceride levels, were also observed in some studies. Conclusions: The reviewed studies provide strong evidence supporting the effectiveness of IF regimens in improving metabolic factors, including weight, insulin sensitivity and lipid profiles in individuals with abnormal glucose metabolism. IF offers a promising dietary strategy potentially providing additional benefits beyond conventional dietary interventions. However, further research is needed to elucidate the long-term effects, optimal fasting protocols and potential mechanisms underlying the benefits of intermittent fasting in these conditions.